The University of Nebraska and U.S. Department of Defense (DOD) have joined forces to develop drug therapies for members of the military who have been exposed to radiation.

For early-stage kidney cancer patients who may be at risk for worsening kidney disease, personalized treatment plans such as undergoing active surveillance and MRI examinations may extend life expectancy, according to new research published Jan. 15 in Radiology.

Walmart and CVS Health will no longer be in the same network for filling prescription drugs after the two companies couldn’t come to a drug pricing agreement, CVS announced.

Personalized treatment plans can benefit early-stage kidney cancer patients, according to a new study published in Radiology.

Long-term sufferers of post-traumatic stress disorder (PTSD) are at a higher risk for circulatory and metabolic diseases, especially if they’re men, according to research out of Siena, Italy.

Ping An Insurance Company of China’s corporate venture fund is investing in AI medical solution company Airdoc, the company announced on Saturday, Jan. 12.

ROCHESTER, N.Y., Jan. 15 — Carestream Health was awarded 42 new patents from the U.S. Patent and Trademark Office last year for innovation in digital radiography, extremity CT imaging and other healthcare technology areas. The company also received 37 additional patents in European and Asian countries last year.

On Jan. 1, U.S. hospitals began posting prices online for all services offered, including medical imaging, in compliance with a new Trump administration order intended to increase transparency for health care consumers. However, according to a recent article from The New York Times, the policy change is "turning into a fiasco.”

Compared to microwave ablation (MWA), radiofrequency ablation (RFA) achieved better overall survival rates (OS) in lung cancer patients, according to a recent study conducted in China. Both were found to be effective and safe treatment methods.

The RAPID neuroimaging platform can now be used in the U.S. to select stroke patients who are likely to benefit from endovascular thrombectomy. It is the first imaging platform to be cleared by the FDA as a patient selection tool for this clot removal procedure, according to iSchemaView, which developed the technology.